ProAxsis Transitions to Independent Growth Company to Advance Respiratory Research
A new fundraise will support commercial scale-up and the development of biomarker technology for respiratory disease drug development.
Category: Products & Treatment
Products & Treatment
Latest
Products & Treatment
Latest
Respiratory Biologics Have Significantly Reduced Asthma Exacerbations
A large-scale study finds that the introduction of asthma biologics in 2015 has led to immediate and sustained reductions in exacerbations at the population level.
Products & Treatment
Latest
Capnography and Pulse Oximetry in the PICU
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Industry & Regulatory News
Latest
American Lung Association Launches COPD Management Program
American Lung Association is launching a new initiative to help the more than 16 million people in the US living with COPD manage symptoms and improve quality of life.
Pharmaceuticals
Latest
Lung Denervation Trial to Target COPD Phenotype
Nuvaira treated the first patient treated in a clinical trial evaluating a one-time lung denervation therapy for patients with specific COPD symptoms.
Diagnostics & Testing
Latest
Cryosurgical System for Bronchoscopic Applications Used in First Human Cases
Cryocision flexible cryocatheter system is the first console-free and wholly single-use flexible cryosurgical system for bronchoscopic applications available in the US and Canada.
Monitoring & Treatment
Latest
Ai Tool to Help Predict Asthma Attacks
A collaboration between Jiva.ai and Aevice Health has developed a predictive model that identifies potential asthma exacerbations up to 72 hours in advance.